Related Experiment Videos
[Immunologic changes in linear scleroderma in children. Apropos of 11 cases]
Annales De Dermatologie Et De Venereologie
|January 1, 1988
Summary
Antinuclear antibodies (ANA) are common in childhood linear scleroderma, appearing in 81% of cases. However, ANA levels did not predict long-term bone or joint complications in these children.
Area of Science:
- Pediatric Rheumatology
- Dermatology
- Immunology
Context:
- Linear scleroderma is a rare autoimmune condition affecting children.
- Immunologic markers are crucial for understanding disease pathogenesis.
- Limited data exists on immunologic findings in pediatric linear scleroderma.
Purpose:
- To analyze immunologic data in children with linear scleroderma.
- To investigate the correlation between immunologic markers and disease characteristics.
- To assess the predictive value of immunologic markers for osteoarticular sequelae.
Summary:
- A retrospective study analyzed 11 children with linear scleroderma.
- Antinuclear antibodies (ANA) were detected in 81% of patients.
- ANA presence correlated with deeper sclerosis but not osteoarticular sequelae; lowered complement and positive immune complexes were also noted.
Impact:
- Highlights the high prevalence of ANA in pediatric linear scleroderma.
- Suggests ANA may indicate deeper tissue involvement.
- Underscores the need for further research into immunologic factors and long-term outcomes.